BPA Call HT001415A0053-0001
Award Date 12/12/14
Potential Completion Date 12/12/14
Potential Value $40K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, with the ID HT001416P0006, was made by the Defense Health Agency to Biogenex Laboratories, a Minority Owned Business, For Profit Organization, Woman Owned Small Business, and Manufacturer of Goods. The $120,000.00 firm fixed price contract is for BASE REQUESTING SERVICE CONTRACT FY16, with a period of performance through October 30, 2020. The contract does not have a set-aside designation. Biogenex Laboratories is the prime contractor, and there are no major...
- This contract was awarded by the Department of the Army Medical Command to Biomerieux Inc., a manufacturer of in vitro diagnostic products, for GN/GP SUSCEPTIBILITY TESTS. The $118,319.58 firm-fixed-price purchase order contract has a completion date of September 30, 2018. Biomerieux Inc. is a foreign-owned, for-profit organization that produces medical diagnostic equipment and supplies. This award is not associated with a set-aside program. Biomerieux Inc. has experience providing a range of...
- This firm-fixed-price purchase order was awarded by the Defense Health Agency (DHA) to Biomerieux Inc., a global leader in in vitro diagnostics. The contract, valued at $11,258.96, is for the provision of Biomerieux supplies and services, including its proprietary VITEK, BioFire, and VIDAS diagnostic platforms and associated reagents and test kits. Biomerieux, through its Biomerieux, Inc. division, has been a long-standing supplier of clinical diagnostic equipment and consumables to various...
- This is a delivery order contract awarded by the Navy Bureau of Medicine and Surgery (BUMED), a Defense agency, to Microgenics Corporation's Clinical Diagnostics Division. The $8,325 firm-fixed price contract is for the supply of beta-glucuronidase, a biochemical used in clinical diagnostic testing. Microgenics is an experienced provider of immunoassay reagent test kits, drug screening products, and related laboratory supplies to support substance abuse testing and treatment programs at military...
- Microgenics Corporation, a clinical diagnostics division of Thermo Electron Corporation, has received a firm fixed price delivery order for $15,048.75 from the Department of the Army Medical Command. This delivery order was awarded on February 24, 2021 with a completion date of February 20, 2024 and is for the provision of 500 ml DRI ECSTASY PLUS MDMA/MDA reagent kits to the Trippler Army Medical Center in Hawaii. Microgenics will perform this order from its location in Fremont, California...
- Microgenics Corporation, a clinical diagnostics manufacturer and subsidiary of Thermo Electron Corporation, has been awarded a delivery order valued at $24,404.40 for the purchase of opiates reagent kits for the Air Force Drug Testing Laboratory. The delivery order, issued under base contract N6264523D5006 with an ultimate completion date of September 15, 2026, will be performed in San Antonio, Texas. This firm fixed-price award carries no set-aside designation, reflecting Microgenics'...
- This is a federal contract awarded by the Defense Health Agency (DHA) to Biomerieux Inc., a global leader in in vitro diagnostics, for the delivery of reagents, materials, and test supplies. The $15,370.43 firm-fixed-price contract has an ultimate completion date of October 15, 2024. Biomerieux Inc., through its Biomerieux, Inc. division, provides a wide range of clinical diagnostic equipment, reagents, and supplies to various federal agencies, including the Departments of Veterans Affairs,...
- The Department of the Navy Bureau of Medicine and Surgery has awarded a delivery order to Microgenics Corporation, a subsidiary of Thermo Electron Corporation, for the supply of benzodiazepine reagent kits. The $50,759.28 firm-fixed price contract has an April 24, 2024 completion date and is being fulfilled under an existing indefinite delivery vehicle (IDV) contract held by Microgenics. Microgenics is a manufacturer of clinical diagnostic products and toxicology testing solutions, and has...
- Biomerieux Inc., through its Biomerieux, Inc. Division, has been awarded a Blanket Purchase Agreement (BPA) call contract by the Indian Health Service, a civilian agency within the U.S. Department of Health and Human Services. The $69,870.49 firm-fixed-price contract is for the provision of BioFire panel reagents under the Invitro Diagnostics, Reagents, Test Federal Supply Schedule contract. This contract does not have a set-aside designation. The contract has an ultimate completion date of July...
- The Department of the Navy Bureau of Medicine and Surgery awarded a $8,134.80 firm fixed price delivery order contract to Microgenics Corporation Clinical Diagnostics Division for DRI OPIATE 500 ML REAGENTS TEST KITS. As the prime contractor, Microgenics will provide the requested test kits to the Navy from its place of performance in Fremont, California, with work expected to be completed by December 13, 2023. The parent company of Microgenics, Thermo Electron Corporation Financial Services...
- HT001415A0053Blanket Purchase Agreement
- HT001415A0053-0001BPA Call
BIOGENEX PRODUCTS
Posted 12/12/14
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $40.0k | 12/12/14 |